NL-OMON52370招募中不适用
Intrarenal T cells & chronic kidney graft rejection; the ITHACA study - ITHACA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-18 years and older
- •-able to give informed consent
- •-clinical diagnosis of chronic rejection for which a renal biopsy is indicated
- •for confirmation
排除标准
- •-known extra risk for bleeding (e.g. clotting disorder or medication)
研究者
相似试验
进行中（未招募）
1 期
T Cell based treatment for patients with Renal Cell CarcinomaAdvanced Renal Cell CarcinomaMedDRA version: 20.0Level: LLTClassification code 10038409Term: Renal cell carcinoma NOSSystem Organ Class: 100000004864EUCTR2016-001454-18-DKCenter for Cancer Immune Therapy6
已完成
不适用
Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant RejectionRenal Failure, ChronicNCT00150891University of Giessen84
进行中（未招募）
不适用
Highly Suppressive Treg in Delayed and Slow Graft Function After Kidney TransplantationDGFKidney Transplant ComplicationsNCT04414111St. Louis University180
Unknown
4 期
CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant RecipientsRenal TransplantNCT00737659Rabin Medical Center138
已完成
不适用
Protective Immunity Project 01Kidney TransplantationImmunityImmunosuppressionNCT00788021Emory University124